🇺🇸 FDA
Patent

US 7309716

Benzimidazoles useful as modulators of ion channels

granted A61PA61P1/00A61P1/02

Quick answer

US patent 7309716 (Benzimidazoles useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16